Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Not Confirmed
Not Confirmed
10-11 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
09-11 June, 2025
Annual Outsourcing in ...Annual Outsourcing in CT
Industry Trade Show
Not Confirmed
10-11 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
06 Jun 2025
// FDA
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218395
01 Apr 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250401009688/en/Jerome-Stevens-Pharmaceuticals-Announces-Acquisition-of-Thyquidity-Levothyroxine-Sodium-Oral-Solution
14 Mar 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/azurity-pharmaceuticals-completes-acquisition-of-covis-pharma-302401898.html
12 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/azurity-pharmaceuticals-inc-announces-availability-of-azmiro-testosterone-cypionate-injection-for-intramuscular-use-ciii-302330509.html
16 Nov 2024
// FIERCE PHARMA
https://www.fiercepharma.com/pharma/fda-nod-azuritys-danziten-allows-patients-take-leukemia-med-without-fasting
14 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/azurity-pharmaceuticals-inc-announces-fda-approval-of-danziten-nilotinib-tablets-the-first-and-only-nilotinib-with-no-mealtime-restrictions-302306329.html
ABOUT THIS PAGE
Azurity Pharma is a supplier offers 1 products (APIs, Excipients or Intermediates).
Find a price of Glucagon bulk offered by Azurity Pharma